GLP-1 Breakthrough: Is Tirzepatide FDA Approved for Diabetes & Weight Loss? [keto luxe gummies reviews]

GLP-1 Breakthrough: Is Tirzepatide FDA Approved for Diabetes & Weight Loss? [keto luxe gummies reviews]

| 1h 28m 28s | Video has closed captioning.

Discover the groundbreaking advancements of Tirzepatide, a dual-receptor agonist targeting GLP-1 and GIP receptors. Learn how it amplifies insulin secretion, reduces food intake, and helps manage weight and diabetes effectively. FDA-approved as Mounjaro® (2022) for type 2 diabetes and Zepbound® (2023) for chronic weight management, Tirzepatide is revolutionizing obesity and diabetes care. 🎥 This sneak peek from our GLP-1 Mini-Course covers: What Tirzepatide is and how it works Its FDA approval journey under two brand names The impact on diabetes and weight management care 📚 Ready to dive deeper? Train with IAPAM and elevate your expertise in medical aesthetics and pharmacotherapy. Click the link below to access the full course and transform your practice! 👉 #Tirzepatide #GLP1 #DiabetesCare #WeightLoss #FDAApproved #IAPAM #nurse #doctor #sidehustle #makemoreworkless